Skip to main content
. 2021 Sep 29;11(10):2842. doi: 10.3390/ani11102842

Table 1.

Effects of bromocriptine and nano-bromocriptine on pause days and egg production percent of late laying hens.

Parameter Pause Days (Day) Egg/Hen/D (%)
76th Week 80th Week 84th Week 76th Week 80th Week 84th Week
Treatment Control (n = 50) 11.07 ± 0.26 a 10.00 ± 0.25 a 11.56 ± 0.34 a 61.42 ± 0.95 c 61.90 ± 0.78 c 51.16 ± 1.42 b
Bromocriptine (n = 50) 7.05 ± 0.32 b 6.89 ± 0.28 b 8.20 ± 0.35 b 71.55 ± 1.25 b 71.11 ± 1.01 b 65.54 ± 1.71 a
Nano-bromocriptine (n = 50) 5.38 ± 0.33 c 5.93 ± 0.26 c 7.27 ± 0.30 c 78.33 ± 1.26 a 74.54 ± 1.16 a 68.13 ± 1.45 a
Administration Orally (n = 75) 7.14 ± 0.39 b 7.15 ± 0.32 b 8.94 ± 0.36 73.37 ± 1.26 a 71.04 ± 1.12 a 62.41 ± 1.62 a
Injection (n = 75) 8.52 ± 0.32 a 8.06 ± 0.24 a 9.08 ± 0.31 67.49 ± 1.04 b 67.33 ± 0.78 b 60.82 ± 1.44 a
Treatment χ
administration
Control (oral, n = 25) 11.11 ± 0.37 a 10.07 ± 0.37 a 11.50 ± 0.48 a 61.15 ± 1.34 d 61.56 ± 1.12 c 51.65 ± 1.99 c
Control (injection, n = 25) 11.04 ± 0.38 a 9.93 ± 0.35 a 11.63 ± 0.48 a 61.69 ± 1.37 d 62.25 ± 1.09 c 50.67 ± 2.05 c
Bromocriptine (oral, n = 25) 6.39 ± 0.37 c 6.11 ± 0.44 c 8.86 ± 0.53 b 74.71 ± 1.50 b 72.75 ± 1.81 b 63.04 ± 2.62 b
Bromocriptine
(injection, n = 25)
7.71 ± 0.49 b 7.68 ± 0.28 b 7.54 ± 0.42 c,d 68.39 ± 1.87 c 69.46 ± 0.84 b 68.05 ± 2.12 a,b
Nano-bromocriptine
(oral, n = 25)
3.93 ± 0.35 d 5.29 ± 0.35 c 6.46 ± 0.44 d 84.26 ± 1.28 a 78.80 ± 1.34 a 72.52 ± 1.92 a
Nano-bromocriptine
(injection, n = 25)
6.82 ± 0.41 c 6.57 ± 0.36 c 8.07 ± 0.34 b,c 72.40 ± 1.58 b,c 70.29 ± 1.55 b 63.75 ± 1.78 b
p-value Treatment <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Administration <0.0001 <0.0026 <0.7091 <0.0001 <0.0007 <0.3572
Interaction <0.0014 <0.0425 <0.0062 <0.0003 <0.0032 <0.0052

Values are presented as least square mean ± SE. a–d Means within the same column for each parameter with different superscripts are statistically different at p < 0.05 (Two-way ANOVA, Tukey post-hoc test).